While the Korea Centers for Disease Control and Prevention (KCDC) ordered a policy to “ban Pfizer” for booster vaccinations for those who were vaccinated against AZ, which was concentrated in their 60s, at a briefing to encourage the 3rd vaccination by the Korea Centers for Disease Control and Prevention, professors said that “Pfizer is the same as modern.”
Professor Nam Jae-hwan (Department of Biomedical Science, Catholic University of Korea) said, "There is no reason why moderna should be vaccinated." "He said during the 3rd vaccination briefing of the Korea Centers for Disease Control and Prevention on the 16th.
KCDC previously said, “We sent an official notice on the ban on selection of Pfizer for AZ inoculations to medical institutions.
The JoongAng Ilbo on the 12th said, "The Korea Centers for Disease Control and Prevention has recently sent an official letter banning the selection of Pfizer for AZ inoculations to front-line medical institutions." There is no problem because my dose is half of the 1.2 dose. “Even countries that ban modern or under 30 years of age at the time of basic vaccination do not ban booster shots.”
Professor Won-seok Choi (the Department of Infectious Diseases in ancient times) said about the three-month shortening policy, “If we look at the risk of serious patients and deaths, and the risk of microns, sufficient evidence has been secured for shortening the period.” Depending on the situation, we are considering shortening the period.”
In the United States, the 3rd dose interval is 6 months for all ages.
According to the World Health Organization's (WHO) Expert Strategic Advisory Group (SAGE), those vaccinated with AZ in the first dose can get the Pfizer/Modern vaccine at the second or 'booster shot', and conversely, the Pfizer/Modena vaccine at the first dose. It was announced on the 16th that the AZ vaccine could be given in the second or booster shot.
Regarding cross-inoculation, the WHO said that the AZ vaccine or Pfizer/Modena vaccine can be received from the first vaccination to the Sinopharm vaccine or the second or booster shot. Reuters reported today that it has announced that it should be considered.
Jung Eun-kyung, head of the Korea Centers for Disease Control and Prevention (KCDC), said in a briefing on the 16th, “If you look at the results of the Israeli study where the third dose was given, it is confirmed that the effect of preventing infection was increased by 11 times and the effect of severe prevention by 20 times compared to those who received the second dose. “After the third vaccination in the elderly aged 60 years and older, it was confirmed that the risk of severe progression and death of confirmed patients decreased by 90% and 100% after the third vaccination,” he said.
Regarding the Moderna intensive vaccination policy, the 3rd vaccination policy announced on the 12th through the JoongAng Ilbo, the head of the inoculation management team at the KCDC, is “No choice other than Moderna.”
In response to the question 'Can I choose a vaccine?', the report said, "In principle, it is impossible. They must have the same vaccine. Pfizer-Pfizer inoculations can book with Pfizer, and Moderna-Modern with Moderna. The AZ-AZ must meet moderna, and Janssen must also meet moderna.”
The Korea Centers for Disease Control and Prevention continued, “Korea has maintained the principle of not being able to select a vaccine,” the Korea Centers for Disease Control and Prevention (KCDC) said in response to a question about whether people with AZ vaccination, such as those aged 60 to 74, cannot choose Pfizer. The same goes for booster shots. If you allow the choice, you are worried that there will be a shortage by focusing on a specific vaccine. However, modern or those subject to inoculation prohibition who cannot be vaccinated can change to Pfizer if they receive permission by submitting a statement of opinion or diagnosis to the public health center. However, it is virtually impossible because there has been no clear evidence of those subject to vaccination.”
The Korea Centers for Disease Control and Prevention's distribution of vaccination history among the dead (over 12 years old from October 10 to December 4) Among 1092 deaths, 549 people vaccinated and 543 people who were not vaccinated, and 486 deaths after the second vaccination were overwhelming. The first inoculation was 62 patients, followed by the third inoculation 1 patient.
The reason for the 8-fold increase in the number of deaths from the second vaccination compared to the first seems to be the result of the government's policy of focusing on vulnerable facilities in nursing homes for additional vaccines, followed by a misjudgment in the prediction of breakthrough infection in the With Corona enforcement policy and the poor response of the medical system.
Professor Nam said at a briefing by the Korea Centers for Disease Control and Prevention on the statistics of death from vaccination, “More than 90% of people in their 60s or older were hit. 90 out of 100 people got the vaccine and 10 didn't. Among them, if there were 10 patients, 5 were from 90 who received the vaccine and 5 from 10 who did not get the vaccine.
On the 17th, Prime Minister Kim Bu-gyeom said, “The EU has recognized that it is very effective in reducing the severity of the development of Celltrion. Doctors seem a little hesitant, so I want to say that you can use it with a little confidence, and that you have seen many clinical results,” he publicly announced through MBC.
The U.S. Centers for Disease Control and Prevention (CDC) announced on the 16th that “We have received data on the occurrence of rare thrombosis more frequently in Janssen vaccine recipients.
Celltrion, which the Moon Jae-in government intensively supported in the early stages of the coronavirus, quadrupled in share price last year, soaring from the high of 400,000 won at the end of the year, to 200,000 won this year even for exporting corona treatment diagnostic kits.
Celltrion Shareholders' Solidarity held a protest meeting on the 15th in response to the stock price drop, and the CEO said, "Even if the overall pharmaceutical and bio stock price was not good this year, Celltrion fell the most." said.
As a result of the previous Korea-US summit, the South Korean government intensively inoculated the reserve forces with 1.1 million doses of the Janssen vaccine provided by the United States.